vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and Idaho Strategic Resources, Inc. (IDR). Click either name above to swap in a different company.
AGIOS PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($20.0M vs $14.6M, roughly 1.4× Idaho Strategic Resources, Inc.). Idaho Strategic Resources, Inc. runs the higher net margin — 64.3% vs -541.1%, a 605.4% gap on every dollar of revenue. On growth, Idaho Strategic Resources, Inc. posted the faster year-over-year revenue change (92.0% vs 86.1%). Idaho Strategic Resources, Inc. produced more free cash flow last quarter ($8.2M vs $-97.3M). Over the past eight quarters, Idaho Strategic Resources, Inc.'s revenue compounded faster (57.2% CAGR vs 56.1%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Idaho Strategic Resources, Inc.IDREarnings & Financial Report
Idaho Strategic Resources, Inc. is a U.S.-based natural resource company focused on the exploration, development, and production of critical and strategic minerals. Primarily operating in Idaho, it targets rare earth elements, gold, silver, and other high-demand minerals, supplying products to the clean energy, defense, and industrial manufacturing sectors across North America.
AGIO vs IDR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $14.6M |
| Net Profit | $-108.0M | $9.4M |
| Gross Margin | 90.6% | 68.5% |
| Operating Margin | -608.9% | 62.4% |
| Net Margin | -541.1% | 64.3% |
| Revenue YoY | 86.1% | 92.0% |
| Net Profit YoY | -11.9% | 220.6% |
| EPS (diluted) | $-1.86 | $0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $14.6M | ||
| Q3 25 | $12.9M | $11.1M | ||
| Q2 25 | $12.5M | $9.5M | ||
| Q1 25 | $8.7M | $7.3M | ||
| Q4 24 | $10.7M | $7.6M | ||
| Q3 24 | $9.0M | $6.2M | ||
| Q2 24 | $8.6M | $6.1M | ||
| Q1 24 | $8.2M | $5.9M |
| Q4 25 | $-108.0M | $9.4M | ||
| Q3 25 | $-103.4M | $3.0M | ||
| Q2 25 | $-112.0M | $2.8M | ||
| Q1 25 | $-89.3M | $1.6M | ||
| Q4 24 | $-96.5M | $2.9M | ||
| Q3 24 | $947.9M | $1.6M | ||
| Q2 24 | $-96.1M | $2.2M | ||
| Q1 24 | $-81.5M | $2.2M |
| Q4 25 | 90.6% | 68.5% | ||
| Q3 25 | 87.0% | 63.6% | ||
| Q2 25 | 86.3% | 57.8% | ||
| Q1 25 | 87.6% | 50.8% | ||
| Q4 24 | 88.3% | 53.3% | ||
| Q3 24 | 91.3% | 48.7% | ||
| Q2 24 | 82.6% | 50.2% | ||
| Q1 24 | 92.3% | 48.1% |
| Q4 25 | -608.9% | 62.4% | ||
| Q3 25 | -907.4% | 23.4% | ||
| Q2 25 | -1020.1% | 26.6% | ||
| Q1 25 | -1222.0% | 19.3% | ||
| Q4 24 | -1165.3% | 36.2% | ||
| Q3 24 | -1146.9% | 23.4% | ||
| Q2 24 | -1228.3% | 34.2% | ||
| Q1 24 | -1124.3% | 36.3% |
| Q4 25 | -541.1% | 64.3% | ||
| Q3 25 | -803.1% | 26.8% | ||
| Q2 25 | -899.4% | 29.2% | ||
| Q1 25 | -1023.3% | 22.1% | ||
| Q4 24 | -899.6% | 38.5% | ||
| Q3 24 | 10574.7% | 25.8% | ||
| Q2 24 | -1115.7% | 35.2% | ||
| Q1 24 | -995.8% | 36.8% |
| Q4 25 | $-1.86 | $0.62 | ||
| Q3 25 | $-1.78 | $0.20 | ||
| Q2 25 | $-1.93 | $0.20 | ||
| Q1 25 | $-1.55 | $0.12 | ||
| Q4 24 | $-1.44 | $0.21 | ||
| Q3 24 | $16.22 | $0.12 | ||
| Q2 24 | $-1.69 | $0.17 | ||
| Q1 24 | $-1.45 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | — |
| Total DebtLower is stronger | — | $2.3M |
| Stockholders' EquityBook value | $1.2B | $108.2M |
| Total Assets | $1.3B | $116.2M |
| Debt / EquityLower = less leverage | — | 0.02× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | — | ||
| Q3 25 | $92.7M | — | ||
| Q2 25 | $80.9M | — | ||
| Q1 25 | $79.0M | — | ||
| Q4 24 | $76.2M | — | ||
| Q3 24 | $253.7M | — | ||
| Q2 24 | $84.5M | $6.3M | ||
| Q1 24 | $118.8M | $5.3M |
| Q4 25 | — | $2.3M | ||
| Q3 25 | — | $3.0M | ||
| Q2 25 | — | $3.3M | ||
| Q1 25 | — | $3.7M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | — | $2.9M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $3.3M |
| Q4 25 | $1.2B | $108.2M | ||
| Q3 25 | $1.3B | $74.3M | ||
| Q2 25 | $1.4B | $49.3M | ||
| Q1 25 | $1.5B | $39.8M | ||
| Q4 24 | $1.5B | $37.7M | ||
| Q3 24 | $1.6B | $33.1M | ||
| Q2 24 | $660.5M | $25.4M | ||
| Q1 24 | $743.9M | $21.6M |
| Q4 25 | $1.3B | $116.2M | ||
| Q3 25 | $1.4B | $83.1M | ||
| Q2 25 | $1.5B | $57.7M | ||
| Q1 25 | $1.6B | $48.1M | ||
| Q4 24 | $1.7B | $44.0M | ||
| Q3 24 | $1.8B | $40.8M | ||
| Q2 24 | $773.1M | $32.2M | ||
| Q1 24 | $849.7M | $28.7M |
| Q4 25 | — | 0.02× | ||
| Q3 25 | — | 0.04× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | — | 0.09× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $10.7M |
| Free Cash FlowOCF − Capex | $-97.3M | $8.2M |
| FCF MarginFCF / Revenue | -487.5% | 56.0% |
| Capex IntensityCapex / Revenue | 5.6% | 17.7% |
| Cash ConversionOCF / Net Profit | — | 1.15× |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | $12.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | $10.7M | ||
| Q3 25 | $-88.2M | $2.4M | ||
| Q2 25 | $-77.1M | $3.5M | ||
| Q1 25 | $-111.5M | $2.4M | ||
| Q4 24 | $-133.2M | $3.2M | ||
| Q3 24 | $-84.2M | $2.5M | ||
| Q2 24 | $-72.6M | $2.6M | ||
| Q1 24 | $-99.9M | $2.6M |
| Q4 25 | $-97.3M | $8.2M | ||
| Q3 25 | $-89.7M | $709.8K | ||
| Q2 25 | $-78.0M | $2.5M | ||
| Q1 25 | $-112.3M | $1.0M | ||
| Q4 24 | $-134.1M | $2.1M | ||
| Q3 24 | $-84.6M | $1.9M | ||
| Q2 24 | $-72.7M | $2.4M | ||
| Q1 24 | $-100.0M | $2.3M |
| Q4 25 | -487.5% | 56.0% | ||
| Q3 25 | -696.5% | 6.4% | ||
| Q2 25 | -626.2% | 26.5% | ||
| Q1 25 | -1286.4% | 13.8% | ||
| Q4 24 | -1250.1% | 28.0% | ||
| Q3 24 | -944.2% | 30.4% | ||
| Q2 24 | -844.4% | 38.7% | ||
| Q1 24 | -1221.2% | 38.3% |
| Q4 25 | 5.6% | 17.7% | ||
| Q3 25 | 12.1% | 15.3% | ||
| Q2 25 | 7.0% | 10.8% | ||
| Q1 25 | 8.8% | 19.4% | ||
| Q4 24 | 9.0% | 13.6% | ||
| Q3 24 | 4.7% | 9.8% | ||
| Q2 24 | 1.8% | 4.3% | ||
| Q1 24 | 1.7% | 5.5% |
| Q4 25 | — | 1.15× | ||
| Q3 25 | — | 0.81× | ||
| Q2 25 | — | 1.28× | ||
| Q1 25 | — | 1.50× | ||
| Q4 24 | — | 1.08× | ||
| Q3 24 | -0.09× | 1.56× | ||
| Q2 24 | — | 1.22× | ||
| Q1 24 | — | 1.19× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
